Article/Intelligence
Garuda Expects to Receive IDR 20T Capital Injection From Indo Government Likely in Form of Assets to Flip Equity Positive
Indonesian flag carrier PT Garuda Indonesia Tbk is slated to receive an around IDR 20 trillion ($1.186 billion) capital injection from the Indonesian government, said two sources familiar with the matter. The injection is most likely to be in the form of assets, said the two sources and a third source familiar.
The injection will help to turn Garuda’s negative equity to positive, said one of the first two sources and the third source, who did not specify the timeframe for the injection.
Garuda reported $1.35 billion negative equity as of Dec. 31, versus negative $1.41 billion as of Sept. 30.
The government transferred on March 22 its entire 64.54% stake in the carrier to PT Biro Klasifikasi Indonesia, an operational holding company under Indonesia’s newly established sovereign wealth fund Daya Anagata Nusantara, or Danantara. The move was viewed positively by investors given the anticipated implied financial support for Garuda as it expands its fleet.
Garuda’s new CEO, Wamildan Tsani, had been tasked by Indonesian President Prabowo Subianto to re-expand the airline. It completed a court-supervised debt restructuring, or PKPU, in 2022, which covered a total of IDR 104.37 trillion ($6.19 billion) debt.
Garuda said in its March 25 released full-year 2024 earnings statement that it plans to operate 186 aircraft by 2026, up from the 96 aircraft as of October 2024 the company disclosed in a November 2024 earnings presentation.
The Indonesian government had a history of providing financial support to the airline.
In February 2021, the government provided IDR 1 trillion to Garuda through mandatory convertible bonds, or MCBs, though the amount fell short of the original plan of IDR 8.5 trillion as the airline was unable to meet the requirements to draw the full amount.
In December 2022, the government provided another IDR 7.5 trillion through a rights issue as part of the airline’s PKPU agreement.
Garuda did not respond to a request for comments.
This publication has been prepared by Octus, Inc. or one of its affiliates (collectively, "Octus") and is being provided to the recipient in connection with a subscription to one or more Octus products. Recipient’s use of the Octus platform is subject to Octus Terms of Use or the user agreement pursuant to which the recipient has access to the platform (the “Applicable Terms”). The recipient of this publication may not redistribute or republish any portion of the information contained herein other than with Octus express written consent or in accordance with the Applicable Terms. The information in this publication is for general informational purposes only and should not be construed as legal, investment, accounting or other professional advice on any subject matter or as a substitute for such advice. The recipient of this publication must comply with all applicable laws, including laws regarding the purchase and sale of securities. Octus obtains information from a wide variety of sources, which it believes to be reliable, but Octus does not make any representation, warranty, or certification as to the materiality or public availability of the information in this publication or that such information is accurate, complete, comprehensive or fit for a particular purpose. Recipients must make their own decisions about investment strategies or securities mentioned in this publication. Octus and its officers, directors, partners and employees expressly disclaim all liability relating to or arising from actions taken or not taken based on any or all of the information contained in this publication. © 2025 Octus. All rights reserved. Octus(TM) and the Octus logo are trademarks of Octus Intelligence, Inc.